CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 72 enrolled
Drug / intervention
Bausch & Lomb 217z Excimer Laserdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00769808
NCT00769808N/ACompleted
CompareCT.gov

A Prospective Trial to Evaluate the Safety and Effectiveness of the Bausch & Lomb Technolas® 217z Laser With Zyoptix® Aspheric Algorithm When Used for the LASIK Treatment of Myopia and Myopic Astigmatism

Bausch & Lomb Incorporated·interventional·Posted Oct 9, 2008·Updated Sep 11, 2020

In Brief

A clinical study evaluating Bausch & Lomb 217z Excimer Laser for Myopia and Astigmatism. Completed, enrolled 72 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate the safety and effectiveness of the Bausch \& Lomb Technolas 217z laser with the investigational Zyoptix Aspheric Algorithm when used for LASIK treatment of myopia and myopic astigmatism.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia, Astigmatism
CountriesCanada
Collaborators--

Timeline

N/ACompletedFinished
2009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 9, 2008
Enrollment StartAug 1, 2008
Primary CompletionMar 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 17.7 years ago

Interventions

Bausch & Lomb 217z Excimer Laserdevice

LASIK correction of myopia and myopic astigmatism